Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Symbol
TRIB
Shares outstanding
433,333,333 shares
Disclosed Ownership
85,800,000 shares
Ownership
20%
Form type
SCHEDULE 13D/A
Filing time
25 Mar 2025, 18:29:02 UTC
Date of event
21 Mar 2025
Previous filing
14 Feb 2025
Next filing
24 Oct 2025

Quoteable Key Fact

"PERCEPTIVE ADVISORS LLC disclosed 20% ownership in Trinity Biotech plc Class A Ordinary Shares, $0.0109 par value per share (TRIB) on 21 Mar 2025."

Quick Takeaways

  • PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Trinity Biotech plc Class A Ordinary Shares, $0.0109 par value per share (TRIB).
  • Disclosed ownership: 20%.
  • Date of event: 21 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 25 Mar 2025, 18:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 20% 85,800,000 0 85,800,000 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001224962
Perceptive Credit Advisors LLC 20% 85,800,000 0 85,800,000 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001877081
Joseph Edelman 20% 85,800,000 0 85,800,000 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001164426
Perceptive Credit Holdings II, L.P. 11% 45,800,000 0 45,800,000 /s/ Joseph Edelman Joseph Edelman
Perceptive Credit Holdings III, L.P. 9.2% 40,000,000 0 40,000,000 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001877078
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .